Scholar Rock Holding buy JPMorgan Chase & Co.
Start price
17:30
/
50%
€46.67
Target price
13.08.27
€54.67
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.08.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time.Scholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
AI-generated
Performance without dividends (%)
| Name | 1w |
|---|---|
| Scholar Rock Holding | - |
| iShares Core DAX® | 0.625% |
| iShares Nasdaq 100 | 1.160% |
| iShares Nikkei 225® | 2.356% |
| iShares S&P 500 | 0.631% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock (SRRK) had its price target raised by JPMorgan Chase & Co. from $56.00 to $63.00. They now have an "overweight" rating on the stock.
Ratings data for SRRK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Scholar Rock Holding
Scholar Rock Holding
Start price
Target price
Perf. (%)
€35.00
16.03.26
16.03.26
€43.68
16.03.27
16.03.27
33.34%
12.08.26
12.08.26
Scholar Rock Holding
Start price
Target price
Perf. (%)
€33.40
18.11.25
18.11.25
€40.55
18.11.26
18.11.26
39.73%
12.08.26
12.08.26
Scholar Rock Holding
Start price
Target price
Perf. (%)
€26.60
14.10.24
14.10.24
€28.40
14.10.25
14.10.25
3.01%
15.10.25
15.10.25
Scholar Rock Holding
Start price
Target price
Perf. (%)
€6.15
03.10.24
03.10.24
€16.32
03.10.25
03.10.25
413.82%
04.10.25
04.10.25